Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Nutt

Showing results (21-30 of 179) with videos related to

Pageof 18
Sort By:
Journal of Neurology, Neurosurgery, and Psychiatry|January 21, 2014
The Hamilton Depression Scale--accelerator or break on antidepressant drug discovery?David Nutt
BMJ (Clinical Research Ed.)|December 11, 2021
UK drugs strategy promises to be tough on criminals, but evidence shows this doesn't workDavid Nutt
Lancet (London, England)|November 14, 2009
Government vs science over drug and alcohol policyDavid Nutt
Journal of Psychopharmacology (Oxford, England)|July 16, 2008
Reply to OCD letterDavid Nutt
Therapeutic Advances in Psychopharmacology|August 29, 2013
Perverse effects of the precautionary principle: how banning mephedrone has unexpected implications for pharmaceutical discoveryDavid Nutt
Dialogues in Clinical Neuroscience|October 23, 2019
Psychedelic drugs-a new era in
psychiatry?
David Nutt
Journal of Psychopharmacology (Oxford, England)|October 25, 2006
Anxiety and OCD - the chicken or the egg?David Nutt, Andrea Malizia
Dialogues in Clinical Neuroscience|October 22, 2015
Biological predictors of pharmacological therapy in anxiety disordersEduard Maron, David Nutt
BMJ (Clinical Research Ed.)|April 24, 2023
Criminalising misuse of nitrous oxideAdam Winstock, David Nutt
Focus (American Psychiatric Publishing)|February 5, 2020
Biological Markers of Generalized Anxiety DisorderEduard Maron, David Nutt
Pageof 18

Showing results (21-30 of 179) with videos related to

Sort By:
Pageof 18
Journal of Neurology, Neurosurgery, and Psychiatry|January 21, 2014
The Hamilton Depression Scale--accelerator or break on antidepressant drug discovery?David Nutt
BMJ (Clinical Research Ed.)|December 11, 2021
UK drugs strategy promises to be tough on criminals, but evidence shows this doesn't workDavid Nutt
Lancet (London, England)|November 14, 2009
Government vs science over drug and alcohol policyDavid Nutt
Journal of Psychopharmacology (Oxford, England)|July 16, 2008
Reply to OCD letterDavid Nutt
Therapeutic Advances in Psychopharmacology|August 29, 2013
Perverse effects of the precautionary principle: how banning mephedrone has unexpected implications for pharmaceutical discoveryDavid Nutt
Dialogues in Clinical Neuroscience|October 23, 2019
Psychedelic drugs-a new era in
psychiatry?
David Nutt
Journal of Psychopharmacology (Oxford, England)|October 25, 2006
Anxiety and OCD - the chicken or the egg?David Nutt, Andrea Malizia
Dialogues in Clinical Neuroscience|October 22, 2015
Biological predictors of pharmacological therapy in anxiety disordersEduard Maron, David Nutt
BMJ (Clinical Research Ed.)|April 24, 2023
Criminalising misuse of nitrous oxideAdam Winstock, David Nutt
Focus (American Psychiatric Publishing)|February 5, 2020
Biological Markers of Generalized Anxiety DisorderEduard Maron, David Nutt
Pageof 18